(Q28236856)

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Hereditary haemorrhagic telangiectasia: a clinical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Intracranial hemorrhage in infants and children with hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Diagnosis and management of gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Real prevalence of pulmonary right-to-left shunt according to genotype in patients with hereditary hemorrhagic telangiectasia: a transthoracic contrast echocardiography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Role of Contrast Echocardiography in Screening for Pulmonary Arteriovenous Malformation in Patients With Hereditary Hemorrhagic Telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Small- and moderate-size right-to-left shunts identified by saline contrast echocardiography are normal and unrelated to migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Estimates of maternal risks of pregnancy for women with hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): suggested approach for obstetric services.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Hereditary hemorrhagic telangiectasia: an overview of diagnosis and management in the molecular era for clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Hereditary hemorrhagic telangiectasia: multi-detector row helical CT assessment of hepatic involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Long-term follow-up in 12 children with pulmonary arteriovenous malformations: confirmation of hereditary hemorrhagic telangiectasia in all cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

SMAD4 mutations found in unselected HHT patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Contrast echocardiography for detection of pulmonary arteriovenous malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Digital subtraction pulmonary arteriography versus multidetector CT in the detection of pulmonary arteriovenous malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Screening for pulmonary and cerebral arteriovenous malformations in children with hereditary haemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Pulmonary arteriovenous malformations in children: outcomes of transcatheter embolotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Pulmonary arteriovenous malformations, hereditary hemorrhagic telangiectasia, and brain abscess.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Worsening of nose bleeding heralds high cardiac output state in hereditary hemorrhagic telangiectasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

The use of a nasal obturator in hereditary haemorrhagic telangiectasia: an alternative to Young's procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Hormonal and antihormonal therapy for epistaxis in hereditary hemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Hormonal therapy for the treatment of gastrointestinal bleeding in hereditary hemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

PAVM Embolization: An Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Pulmonary arteriovenous malformations and migraine: a new vision

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Liver involvement in hereditary hemorrhagic telangiectasia (HHT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Liver involvement in hereditary hemorrhagic telangiectasia: CT and clinical findings do not correlate in symptomatic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Bevacizumab in hereditary hemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Defective angiogenesis in mice lacking endoglin

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Endoglin plays distinct roles in vascular smooth muscle cell recruitment and regulation of arteriovenous identity during angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Arteriovenous malformations in mice lacking activin receptor-like kinase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Endoglin-deficient mice, a unique model to study hereditary hemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Angiogenesis and hereditary hemorrhagic telangiectasia. Rendu-Osler-Weber disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Update on molecular diagnosis of hereditary hemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Molecular diagnosis in hereditary hemorrhagic telangiectasia: findings in a series tested simultaneously by sequencing and deletion/duplication analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP-HHT syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Mutations in endoglin and in activin receptor-like kinase 1 among Danish patients with hereditary haemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Hereditary hemorrhagic telangiectasia: ENG and ALK-1 mutations in Dutch patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

High frequency of ENG and ALK1/ACVRL1 mutations in German HHT patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Clinical and analytical sensitivities in hereditary hemorrhagic telangiectasia testing and a report of de novo mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

DHPLC-based mutation analysis of ENG and ALK-1 genes in HHT Italian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

ENG mutations in MADH4/BMPR1A mutation negative patients with juvenile polyposis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Clinical symptoms according to genotype amongst patients with hereditary haemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

Evidence of Small-Bowel Involvement in Hereditary Hemorrhagic Telangiectasia: a Capsule-Endoscopic Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32

BMPR2mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E3182136D32